Study of apoptosis-related interactions in colorectal cancer
Himanshu Arora1, Rehana Qureshi2, M A Rizvi2
1School of Studies in Zoology and Biotechnology, Vikram University, Ujjain, MP, India. himanshu.harora@gmail.com.
Abstract:
Abnormalities in apoptotic functions contribute to the pathogenesis of colorectal cancer. In this study, molecular interactions behind the apoptotic regulation have been explored. For this purpose, enrichment analysis was performed considering microRNAs (miRNAs) that putatively target TP53 and altered during colon cancer. This revealed gene associated with both TP53 and miRNAs. Further analysis showed that a significant molecular interaction between the shortlisted candidates (TP53, miR-143, KRAS, BCL2, and PLK1) exists. Mutation study was conducted to confirm the clinical relevance of candidates. It showed that the mutation extent does not significantly alter survival in patients thus making these candidates suitable as drug targets. Overall, we showed the importance of interactions between TP53, miR-143, KRAS, BCL2, and PLK1 with respect to colorectal cancer using bioinformatics approach.
Insights
Dysregulated apoptosis is key in colorectal cancer. This study identifies crucial molecular interactions involving TP53, miR-143, KRAS, BCL2, and PLK1 as potential drug targets.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Apoptotic dysfunction is a significant factor in colorectal cancer development.
- Understanding molecular mechanisms regulating apoptosis is crucial for targeted therapies.
Purpose of the Study:
- To explore molecular interactions governing apoptotic regulation in colorectal cancer.
- To identify key genes and microRNAs involved in colorectal cancer pathogenesis.
- To evaluate the potential of identified molecular players as therapeutic targets.
Main Methods:
- Utilized enrichment analysis to identify microRNAs targeting TP53 in colon cancer.
- Performed molecular interaction analysis on shortlisted candidates: TP53, miR-143, KRAS, BCL2, and PLK1.
- Conducted mutation studies to assess the clinical relevance and drug target suitability of identified candidates.
Main Results:
- Identified significant molecular interactions between TP53, miR-143, KRAS, BCL2, and PLK1.
- Mutation analysis indicated that the extent of mutations in these candidates does not significantly impact patient survival.
- These findings highlight the selected genes and microRNA as promising drug targets.
Conclusions:
- The study elucidates critical molecular interactions essential for apoptotic regulation in colorectal cancer.
- TP53, miR-143, KRAS, BCL2, and PLK1 represent viable therapeutic targets for colorectal cancer treatment.
- Bioinformatics approaches are effective in uncovering complex molecular networks in cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...


